NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the expansion of its state-of-the-art affiliated pharmacy to include advanced non-sterile compounding capabilities for oral and topical medications. This milestone extends LifeMD’s pharmacy growth strategy by enabling its vertically integrated platform to deliver tailored therapies designed to meet evolving patient needs while improving efficiency and reducing relian ...

Core Insights - LifeMD, Inc. is a leading provider of virtual primary care services, offering telemedicine and access to various healthcare services across more than 200 conditions [1][2] - The company will participate in two investor conferences in June, focusing on topics related to consumer and enterprise healthcare solutions [2] Company Overview - LifeMD provides a vertically integrated digital care platform, a 50-state affiliated medical group, and a 22,500-square-foot affiliated pharmacy [1] - The services offered include primary care, men's and women's health, weight management, and hormone therapy [1] Upcoming Events - Management will participate in the BTIG Obesity Health Forum on June 18, discussing "Direct to Consumer vs. Direct to Enterprise" [2] - The company will also be present at the Truist Securities Healthcare Disruptors & Digital Health Conference on June 24-25, with a panel discussion on "Tailored Approach to Weight Loss Solutions" [2]

Core Viewpoint - LifeMD, Inc. is enhancing its weight management program by integrating access to Wegovy (semaglutide) through NovoCare Pharmacy, providing cash-pay patients with streamlined access to this FDA-approved medication [1][2][3] Group 1: Company Overview - LifeMD is a leading provider of virtual primary care services, offering telemedicine, lab testing, and pharmacy services across more than 200 conditions [5] - The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, and a national diagnostic lab network to improve access to affordable healthcare [5] Group 2: Product Offering - The integration with NovoCare Pharmacy allows LifeMD to offer all FDA-approved dose strengths of Wegovy directly within its virtual care platform [1][4] - Wegovy is the first GLP-1 therapy approved in the U.S. for chronic weight management and cardiovascular risk reduction in adults with obesity [4] Group 3: Market Position and Strategy - LifeMD's weight management program is one of the fastest-growing cash-pay offerings in the U.S., providing virtual consultations, lab testing, and prescriptions for anti-obesity medications [2][3] - The company aims to reduce barriers for patients seeking access to life-changing medications like Wegovy, enhancing the overall patient experience [3]